Tricuspid heart valve repair and its effect on gut health
Part of Heart & circulation clinical trials.
This study looks at how fixing a severe leaky right heart valve (tricuspid regurgitation) with a device called T-TEER affects the bacteria in your gut and how your stomach and intestines work. It may help understand if heart valve repair can improve gut-related symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a severe leaky right heart valve (tricuspid regurgitation)
- You are going to have a procedure called T-TEER to fix the valve
- You do not have other serious heart valve problems, like severe mitral valve leak
- You do not have active infections, gut diseases, previous gut surgery, or active cancer
- You have not taken antibiotics or probiotics in the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study tracks patients with weak heart pumps and leaky tricuspid valves (a valve on the right side of the heart) who receive a minimally invasive repair procedure. The goal is to understand how this treatment affects patients' heart function and quality of life over time.
This study tracks how well the TriClip device works and how safe it is after it's placed in your heart to repair a leaky valve. You'll attend follow-up visits so doctors can monitor your recovery and device function over time.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This study tests a new catheter-based device (inserted through a vein, not open surgery) to repair a leaky tricuspid heart valve in patients who remain symptomatic despite taking medications. The goal is to improve heart function and quality of life.
This trial tests a new robotic catheter procedure to repair a leaky tricuspid valve (the valve on the right side of your heart). Instead of open-heart surgery, doctors thread a tiny device through a vein in your neck to fix the valve. It may be an option if you have severe leaking and your heart team thinks surgery is too risky for you.
Hear when a new Tricuspid Regurgitation (TR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.